Alcoholic Fatty Liver Blood Test Results Explained

Alcoholic fatty liver blood test results can be confusing to interpret, and understanding what they mean is an important step towards protecting your liver health. Blood tests such as liver function tests, a full blood count, and markers like GGT and MCV are used together to assess alcohol-related liver disease, but no single result tells the whole story. This article explains which tests are used, how doctors interpret abnormal findings, what patterns suggest alcohol-related fatty liver, what happens next, and whether results can improve with lifestyle changes.

What blood tests are used to assess suspected alcohol-related fatty liver?

Liver function tests, full blood count, GGT, prothrombin time, and viral hepatitis serology are used together to assess alcohol-related fatty liver, as no single test is diagnostic on its own.

Several blood tests are used together to investigate alcohol-related liver disease (ARLD), and no single test is diagnostic on its own. The most commonly requested panel is a liver function test (LFT), which measures enzymes and proteins produced by the liver, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), bilirubin, and albumin. A full blood count (FBC) is also routinely requested, as alcohol misuse can cause anaemia, changes in red blood cell size (mean corpuscular volume, or MCV), and a low platelet count, which can indicate portal hypertension in more advanced disease.

Additional tests that a GP or specialist may request include:

• Viral hepatitis serology (HBsAg, HCV antibody/antigen): to exclude hepatitis B and C as contributing or alternative causes, as recommended in UK primary care practice

• Carbohydrate-deficient transferrin (CDT): a marker that rises with sustained heavy alcohol consumption; phosphatidylethanol (PEth) is an alternative biomarker available in some centres^[7][8]

• Prothrombin time (PT) or INR: reflects the liver's ability to produce clotting factors

• Serum ferritin and iron studies: to help exclude haemochromatosis as a contributing cause

• Fasting lipid profile and glucose: relevant because metabolic factors often coexist with alcohol-related liver disease

These tests are typically interpreted alongside a thorough clinical history, including an honest account of alcohol intake, and may be supplemented by imaging such as an ultrasound scan. NICE guidance on alcohol-use disorders (CG115) recommends that clinicians assess for liver disease in people who drink at harmful or dependent levels, making blood testing a key part of that assessment.^[1][2]

It is important to note that liver function tests can be within the normal range even when significant alcohol-related liver disease, including cirrhosis, is present. Normal results therefore do not exclude serious underlying liver damage, and clinical assessment remains essential.

How do doctors interpret abnormal liver function test results?

Doctors look for patterns such as an AST:ALT ratio greater than 2:1, raised GGT, elevated MCV, and falling albumin, interpreting these together with clinical history rather than any single value in isolation.

Doctors interpret abnormal liver function test results by considering the pattern of enzyme elevation, the degree of abnormality, and the clinical context rather than treating any single raised value in isolation. In alcohol-related liver disease, a raised AST that is disproportionately higher than ALT, with an AST:ALT ratio greater than 2:1, is a well-recognised pattern. This ratio is most characteristic of alcoholic hepatitis; in simpler alcohol-related fatty liver (steatosis) without hepatitis, the ratio may be lower, and enzyme elevations can be modest even in advanced disease. This pattern differs from viral hepatitis or metabolic fatty liver disease, where ALT tends to be equal to or higher than AST.^[6][5]

GGT is particularly sensitive to alcohol exposure and is frequently elevated even when other liver enzymes remain within the normal range.^[4][8] A raised GGT alongside a raised MCV on the full blood count can strongly suggest alcohol as the underlying cause, though neither finding is specific on its own. Bilirubin rises when the liver's ability to process waste products is impaired, and a significantly elevated bilirubin alongside a prolonged prothrombin time indicates more advanced liver dysfunction.

Albumin, which is produced by the liver, tends to fall as liver function deteriorates over time. A low albumin in the context of other abnormal results suggests that the liver's synthetic function is compromised, which is a more serious finding than enzyme elevation alone. A low platelet count may indicate portal hypertension and warrants further assessment. Doctors also consider whether results are improving or worsening over serial measurements, as trends over time are often more informative than a single set of values.

Jaundice combined with a prolonged INR or signs of encephalopathy suggests liver decompensation and warrants same-day specialist or hospital assessment. Referral to a hepatologist or gastroenterologist is typically considered when results suggest significant liver injury or when the diagnosis is uncertain, in line with NICE NG50 and BSG guidance on abnormal liver blood tests.^[3][4]

Which blood test results suggest alcohol-related fatty liver rather than other causes?

An AST:ALT ratio greater than 2:1, raised GGT, and elevated MCV together most strongly suggest alcohol-related liver disease, distinguishing it from metabolic fatty liver disease where ALT tends to equal or exceed AST.

An AST:ALT ratio greater than 2:1, combined with a raised GGT and an elevated MCV, is the blood test pattern most suggestive of alcohol-related liver disease rather than other liver conditions. This combination reflects the specific metabolic effects of alcohol on the liver and on red blood cell production. It is most strongly associated with alcoholic hepatitis; in uncomplicated alcohol-related fatty liver, the ratio may be lower. By contrast, metabolic dysfunction-associated steatotic liver disease (MASLD, previously termed non-alcoholic fatty liver disease or NAFLD) typically produces a pattern where ALT is equal to or higher than AST, and GGT may be only mildly elevated or normal.^[6][10] Both terms remain in use in UK clinical materials.

Viral hepatitis (hepatitis B and C) can cause significant ALT and AST elevation but is distinguished by specific viral serology tests. Autoimmune hepatitis tends to produce very high transaminase levels alongside positive autoantibodies. Haemochromatosis is associated with raised ferritin and transferrin saturation. Primary biliary cholangitis characteristically raises ALP and GGT with positive anti-mitochondrial antibodies. In younger patients or those with atypical features, rarer causes such as Wilson's disease (assessed with serum caeruloplasmin) and alpha-1 antitrypsin deficiency may also be considered. These alternative diagnoses are important to exclude, and a GP will often request additional blood tests to do so.

It is worth noting that alcohol-related fatty liver disease and metabolic fatty liver disease can coexist, particularly in people who are overweight or have type 2 diabetes. In such cases, the blood test pattern may be mixed, and clinical judgement alongside imaging is needed to determine the relative contribution of each cause. CDT is a more specific marker of recent heavy alcohol use and may be requested when the history is unclear or when objective evidence of alcohol consumption is needed to guide management decisions. PEth is an alternative biomarker available in some UK centres.

What happens after you receive abnormal liver blood test results?

Mildly abnormal results are typically managed with alcohol reduction and repeat testing after four to eight weeks, while significantly abnormal results or signs of decompensation warrant urgent specialist referral or hospital assessment.

After receiving abnormal liver blood test results, the next steps depend on the degree of abnormality, the likely underlying cause, and whether there are any symptoms or signs of more advanced liver disease. For mildly abnormal results in someone with a clear history of alcohol use, a GP will typically advise reducing or stopping alcohol consumption and arrange repeat blood tests after four to eight weeks to assess whether results improve. This period of abstinence is itself diagnostically useful, as alcohol-related fatty liver disease often shows measurable improvement in liver enzymes within weeks of stopping drinking.

Important safety note: people who drink heavily and regularly may be physically dependent on alcohol. Stopping abruptly without medical supervision can cause serious withdrawal symptoms, including seizures.^[13][14] Anyone who suspects they may be dependent on alcohol should speak to their GP before making sudden changes to their intake. Thiamine (vitamin B1) supplementation is often recommended for people with significant alcohol use, as deficiency is common and can cause serious neurological harm.^[15][16]

If results are significantly abnormal, if there is clinical concern about cirrhosis, or if the diagnosis is uncertain, a GP will usually refer to a gastroenterologist or hepatologist. Jaundice, a rising INR, confusion, or gastrointestinal bleeding suggest liver decompensation and require same-day hospital assessment. A liver ultrasound scan is commonly arranged to assess the liver's size, texture, and echogenicity, and to look for signs of cirrhosis or portal hypertension. In some cases, a FibroScan (transient elastography) may be used to estimate liver stiffness as a non-invasive measure of fibrosis, in line with NICE NG50 pathways.^[3][11]

Support for reducing alcohol intake is an important part of management. NICE guidance (CG115 and CG100) recommends that clinicians offer brief advice and, where appropriate, referral to structured alcohol treatment services.^[1][2] Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review, which may be relevant for people seeking support with related health concerns. People with symptoms such as jaundice, significant abdominal swelling, or confusion should contact their GP urgently or call 999 if symptoms are severe, as these may indicate serious liver decompensation.

Can alcoholic fatty liver blood test results improve over time?

Yes, alcohol-related fatty liver is the most reversible stage of liver disease, and enzyme levels such as AST, ALT, and GGT can return to normal within four to eight weeks of sustained abstinence in many people.

Alcohol-related fatty liver blood test results can improve significantly over time, and in many cases they return to normal with sustained abstinence from alcohol. Alcohol-related fatty liver is considered the earliest and most reversible stage of alcohol-related liver disease.^[17][18] Clinical evidence indicates that liver enzyme levels, including AST, ALT, and GGT, can begin to fall within days to weeks of stopping drinking, with many people achieving normal or near-normal results within four to eight weeks of abstinence, though individual variation is considerable.^[17][18]

Important safety note: people who are dependent on alcohol should not stop drinking abruptly without medical advice, as withdrawal can be dangerous. A GP can advise on medically assisted withdrawal where appropriate, and thiamine supplementation is often recommended to reduce the risk of neurological complications. NHS alcohol services and specialist alcohol treatment programmes can provide structured support.

The extent and speed of improvement depends on several factors, including the duration and quantity of previous alcohol use, whether there is underlying fibrosis or cirrhosis, and the presence of other conditions such as obesity or type 2 diabetes. In people with simple fatty liver and no significant fibrosis, the liver has a considerable capacity for recovery. However, if alcohol use has continued over many years and fibrosis has developed, some degree of structural change may persist even after abstinence, and results may not fully normalise. It is also important to note that normalisation of liver enzyme levels does not necessarily mean that fibrosis is absent; ongoing assessment through local pathways, which may include elastography, may be appropriate.

Regular monitoring with repeat blood tests is important to track progress and to identify any worsening that might suggest progression to more advanced disease. A GP will typically arrange follow-up tests at intervals determined by the initial severity of results. Lifestyle changes beyond alcohol reduction, including a balanced diet, regular physical activity, and weight management where relevant, can also support liver recovery and contribute to improving blood test results over time. People who find it difficult to reduce their alcohol intake should be encouraged to seek support from their GP or a specialist alcohol service, as medically assisted withdrawal may be appropriate in some cases.

Scientific References

1. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (CG115).
2. Alcohol-use disorders: diagnosis, assessment and management – Recommendations (CG115).
3. Cirrhosis in over 16s: assessment and management (NG50).
4. Guidelines on the management of abnormal liver blood tests (BSG/Newsome PN et al.).
5. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than non-alcoholic fatty liver disease (Nyblom H et al.).
6. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease (Sheth SG et al.).
7. Comparison of the Diagnostic Value of Phosphatidylethanol (PEth) and Carbohydrate-Deficient Transferrin (CDT) (Årving A et al.).
8. Biomarkers and Clinical Laboratory Detection of Acute and Chronic Ethanol Use (Skipper CP et al.).
9. Phosphatidylethanol in patients with liver diseases of different etiologies: Analysis of six homologues and comparison with other alcohol markers (Andresen-Streichert H et al.).
10. Metabolic dysfunction-associated steatotic liver disease (NG49).
11. FibroScan for assessing liver fibrosis and cirrhosis – Consultation document (HTG682).
12. NICE Diagnostics Assessment Programme: FibroScan (transient elastography).
13. Alcohol dependence – Treatment summaries (BNF).
14. Alcohol-use disorders: diagnosis and management of physical complications (CG100).
15. Alcohol-use disorders: diagnosis and management of physical complications – Recommendations (CG100).
16. Thiamine (vitamin B1) treatment in patients with alcohol dependence (Dervaux A, Laqueille X).
17. Alcohol-related liver disease (ARLD).
18. The prognosis and outcome of alcoholic liver disease (Leevy CM et al.).

Frequently Asked Questions